Nitric oxide in the vasculature: Physiology and pathophysiology

Annals of the New York Academy of Sciences

Volumn 811, Issue , 1997, Pages 60-69

  Moncada, S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ATHEROSCLEROSIS; BLOOD VESSEL TONE; CONFERENCE PAPER; HEART MUSCLE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTIMA; MACROPHAGE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0030790275     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb51989.x     Document Type: Conference Paper

References (52)

1. FURCHGOTT, R. F. & J. V. ZAWADZKI. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
2. PALMER, R. M. J., D. S. ASHTON & S. MONCADA. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666.
3. MONCADA, S., R. M. J. PALMER & E. A. HIGGS. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142.
4. NAVARRO, J., A. SANCHEZ, J. SAIZ, L. M. RUILOPE, J. GARCIA-ESTAN, J. C. ROMERO, S. MONCADA & V. LAHERA. 1994. Hormonal, renal and metabolic alterations during the hypertension induced by chronic inhibition of nitric oxide in rats. Am. J. Physiol. 267: R1516-R1521.
5. MONCADA, S. & A. HIGGS. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012.
6. G-monomethyl-L-arginine-induced pressor response at developmental and established stages in spontaneously hypertensive rats. J. Pharmacol. Exp. Therap. 259: 52-57.
7. KELM, M., M. FEELISCH, T. KREBBER, A. DEUSSEN, W. MOTZ & B. E. STRAUER. 1995. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Hypertension 25: 1-8.
8. CHIU, E. K. Y., H. WANG & J. R. MCNEILL. 1992. Role of sodium and water excretion in the antihypertensive effect of vasopressin in the spontaneously hypertensive rat. Can. J. Physiol. Pharmacol. 70: 1309-1314.
9. TOBIAN, L., J. LANGE, S. AZAR, J. IWAI, D. KOOP, K. COFFEE & M. A. JOHNSON. 1978. Reduction of natriuretic capacity and renin release in isolated blood perfused kidneys of Dahl hypertension-prone rats. Circ. Res. 43: I-92-I-97.
10. LUSCHER, T. F., L. RAIJ & P. M. VANHOUTTE. 1987. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension (Dallas) 9: 157-163.
11. CHEN, P. Y., P. L. ST. JOHN, K. A. KIRK, D. R. ABRAHAMSON & P. W. SANDERS. 1993. Hypertensive nephrosclerosis in the Dahl/Rapp rat. Initial sites of injury and effect of dietary L-arginine supplementation. Lab. Invest. 68: 174-184.
12. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am. J. Physiol. 261: F1033-F1037.
13. REES, D., D. BEN-ISHAY & S. MONCADA. 1996. Nitric oxide and the regulation of blood pressure in the hypertension-prone and hypertension-resistant Sabra rat. Hypertension 28: 367-371.
14. CACHOFEIRO, V., T. SAKAKIBARA & A. NASJLETTI. 1992. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension 19: 138-145.
15. GRAFE, M., C. BOSSALLER, K. GRAF, W. AUCH-SCHWELK, C. R. BAUMGARTEN, A. HILDEBRANDT & E. FLECK. 1993. Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells. Am. J. Physiol. 264: H1493-H1497.
16. WEINER, C. P., I. LIZASOAIN, S. A. BAYLIS, R. G. KNOWLES, I. C. CHARLES & S. MONCADA. 1994. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. USA 91: 5212-5216.
17. RADOMSKI, M. W. & S. MONCADA. 1991. Biological role of nitric oxide in platelet function. In Clinical Relevance of Nitric Oxide in the Cardiovascular System. S. Moncada, E. A. Higgs & J. R. Berrazueta, Eds.: 45-56. Edicomplet. Madrid.
18. KUBES, P., M. SUZUKI & D. N. GRANGER. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88: 4651-4655.
19. GARG, U. C. & A. HASSID. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777.
20. CREAGER, M. A., S. J. GALLAGHER, X. J. GIRERD, S. M. COLEMAN, V. J. DZAU & J. P. COOKE. 1992. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 90: 1248-1253.
21. TSAO, P. S., G. THEILMEIER, A. H. SINGER, L. L.-K. LEUNG & J. P. COOKE. 1994. L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits. J. Arterioscler. Thromb. 14: 1529-1533.
22. MCNAMARA, D. B., B. BEDI, H. AURORA, L. TENA, L. J. IGNARRO, P. J. KADOWITZ & D. L. AKERS. 1993. L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem. Biophys. Res. Commun. 193: 291-296.
23. FARHY, R. D., O. A. CARRETERO, K. L. HO & A. G. SCICLI. 1993. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ. Res. 72: 1202-1210.
24. DE BELDER, A. J., R. MACALLISTER, M. W. RADOMSKI, S. MONCADA & P. J. VALLANCE. 1994. Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc. Res. 28: 691-694.
25. LANGFORD, E. J., A. S. BROWN, R. J. WAINWRIGHT, A. J. DE BELDER, M. R. THOMAS, R. E. A. SMITH, M. W. RADOMSKI, J. F. MARTIN & S. MONCADA. 1994. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet 344: 1458-1459.
26. REES, D. D., S. CELLEK, R. M. J. PALMER & S. MONCADA. 1990. Dexamethasone prevents the induction by endotoxin of nitric oxide syntnase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem. Biophys. Res. Commun. 173: 541-547.
27. VALLANCE, P. & S. MONCADA. 1993. Role of endogenous nitric oxide in septic shock. New Horizons 1: 77-87.
28. HIBBS, J. B. JR., D. WESTENFELDER, R. TAINTOR, Z. VAVRIN, C. KABLITZ, R. L. BARANOWSKI, J. H. WARD, R. L. MENLOVE, M. P. MCMURRAY, J. P. KUSHNER & W. E. SAMLOWSKI. 1992. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89: 867-877.
29. HIBBS, J. B. JR., R. R. TAINTOR, Z. VAVRIN, D. L. GRANGER, J-C. DRAPER, I. J. AMBER & J. R. LANCASTER, JR. 1989. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In Nitric Oxide from L-arginine: A Bioregulatory System. S. Moncada & E. A. Higgs, Eds.: 189-223. Excerpta Medica. Amsterdam.
30. LEPOIVRE, M., J. M. FLAMAN & Y. HENRY. 1992. Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. J. Biol. Chem. 267: 22994-23000.
31. GRYGLEWSKI, R. J., R. M. J. PALMER & S. MONCADA. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (London) 320: 454-456.
32. BECKMAN, J. S., T. W. BECKMAN, J. CHEN, P. A. MARSHALL & B. A. FREEMAN. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624.
33. RADI, R., J. S. BECKMAN, K. M. BUSH & B. A. FREEMAN. 1991. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266: 4244-4250.
34. RADI, R., J. S. BECKMAN, K. M. BUSH & B. A. FREEMAN. 1991. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288: 481-487.
35. HOGG, N., V. M. DARLEY-USMAR, A. GRAHAM & S. MONCADA. 1993. Peroxynitrite and atherosclerosis. Biochem. Soc. Trans. 21: 358-362.
36. VAN DER VLIET, A., C. A. O'NEIL, B. HALLIWELL, C. E. CROSS & H. KAUR. 1994. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. Evidence for hydroxyl radical production from peroxynitrite. FEBS Lett. 339: 89-92.
37. VILLA, L. M., E. SALAS, V. M. DARLEY-USMAR, M. W. RADOMSKI & S. MONCADA. 1994. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc. Natl. Acad. Sci. USA 91: 12383-12387.
38. MORO, M. A., V. M. DARLEY-USMAR, D. A. GOODWIN, N. G. READ, R. ZAMORA-PINO, M. FEELISCH, M. W. RADOMSKI & S. MONCADA. 1994. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc. Natl. Acad. Sci. USA 91: 6702-6706.
39. LIZASOAIN, I., M. A. MORO, R. G. KNOWLES, V. DARLEY-USMAR & S. MONCADA. 1996. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem. J. 314: 877-880.
40. MARLETTA, M. A., P. S. YOON, R. IYENGAR, C. D. LEAF & J. S. WISHNOK. 1988. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27: 8706-8711.
41. HIBBS, J. B., JR., R. R. TAINTOR, Z. VAVRIN & E. M. RACHLIN. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157: 87-94.
42. NATHAN, C. F. & J. B. HIBBS, JR. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3: 65-70.
43. LANGREHR, J. M., R. A. HOFFMAN, J. R. LANCASTER, JR. & R. L. SIMMONS. 1993. Nitric oxide: a new endogenous immunomodulator. Transplantation 55: 1205-1212.
44. DENIS, M. 1991. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium. Killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leuk. Biol. 49: 380-387.
45. BUKRINSKY, M. I., H. S. NOTTET, H. SCHMIDTMAYEROVA, L. DUBROVSKY, C. R. FLANAGAN, M. E. MULLINS, S. A. LIPTON & H. E. GENDELMAN. 1995. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1) infected monocytes: implications for HIV-associated neurological disease. J. Exp. Med. 181: 735-745.
46. DE MARIA, R., M. G. CIFONE, R. TROTTA, M. R. RIPPO, C. FESTUCCIA, A. SANTONI & R. TESTI. 1994. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J. Exp. Med. 180: 1999-2004.
47. VOULDOUKIS, I., V. RIVEROS-MORENO, B. DUGAS, F. OUAAZ, P. BECHEREL, P. DEBRE, S. MONCADA & M. D. MOSSALAYI. 1995. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcεRII/CD23 surface antigen. Proc. Natl. Acad. Sci. USA 92: 7804-7808.
48. LEIBOVICH, S. J., P. J. POLVERINI, T. W. FONG, L. A. HARLOW & A. E. KOCH. 1994. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA 91: 4190-4194.
49. KONTUREK, S. J., T. BRZOZOWSKI, J. MAJKA, J. PYTKO-POLONCZYK & J. STACHURA. 1993. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur. J. Pharmacol. 239: 215-217.
50. O'BRIEN, E. R., M. R. GARVIN, R. DEV, D. K. STEWART, T. HINOHARA, J. B. SIMPSON & S. M. SCHWARTZ. 1994. Angiogenesis in human coronary atherosclerotic plaques. Am. J. Pathol. 145: 883-894.
51. JENKINS, D. C., I. G. CHARLES, L. L. THOMSEN, D. W. MOSS, L. S. HOLMES, S. A. BAYLIS, P. RHODES, K. WESTMORE, P. C. EMSON & S. MONCADA. 1995. Role of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92: 4392-4396.
52. XIE, K., S. HUANG, Z. DONG, S-H. JUANG, M. GUTMAN, Q. XIE, C. NATHAN & I. J. FIDLER. 1995. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181: 1333-1343.